The strategic advantages of partnering with a CRDMO
In this feature, European Pharmaceutical Manufacturer speaks with John McDermott, Vice President of Scientific Consulting at Quotient Sciences.
John explains how CRDMOs, which integrate capabilities of CROs and CDMOs, streamline the drug development process, reduce handoffs, and accelerate timelines. He highlights Quotient Sciences’ Translational Pharmaceutics® platform, a pioneering approach that unifies formulation, manufacturing, and clinical testing into a seamless process.
This integration not only enhances efficiency and reduces costs but also enables real-time decision-making and adaptive development strategies, ultimately bringing new therapies to patients faster.
Read the full article on European Pharmaceutical Manufacturer.
"CRDMOs offer a number of strategic and operational benefits for pharmaceutical and biotech companies... By consolidating services under one roof, CRDMOs eliminate the need for multiple handoffs between vendors."
-John McDermott
What advantages does integration offer in drug development?
Integration in drug development—especially through platforms like CRDMOs or unified development models— is central to achieving success. The productivity of our industry during the pandemic showed what can be achieved when we truly work together. Major advantages can be achieved including enhancements in efficiency, quality, and reduction of development costs.
Quotient Sciences pioneered this approach with Translational Pharmaceutics®, which brings formulation development, manufacturing, and clinical testing together within a single organization.
How and when is Translational Pharmaceutics applied by development teams?
Translational Pharmaceutics® is particularly valuable in early-phase development, supporting both first-in-human studies with flexible, on-demand supply and rapid formulation optimisation through iterative clinical testing—helping teams progress more efficiently from lab to clinic.
For more insight, read the full article on European Pharmaceutical Manufacturer.